[The socioeconomic aspects of the therapeutic measures in lymphogranulomatosis].
The socioeconomic impact of procedures used in the treatment for Hodgkin's disease was studied on the basis of follow-up data. The first-year costs appeared maximal, viz. approximately 3904.78 rubles per patient. The cost effectiveness of the first-, first two- and first three-year treatment was 8.2, 4.8 and 3.5 higher than the overall costs, respectively. Comparison of costs of treatment and maintenance of the whole of patients with the expected cost effectiveness assuring that at least one-third of rehabilitated patients resume working showed the latter parameter to exceed the overall costs by 1.4 times.